Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000101

EVP, Chief Scientific Officer sold 848 shares at $480.95 ($407,846)

  • EVP, Chief Scientific Officer gave up 3,971 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ALTSHULER DAVID · EVP, Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-24 Shares withheld for taxes : show line 1 in the form 10b5-1 −3,971 $483.28 $1,919,105 41,048 D
2025-02-25 Sale : show line 2 in the form 10b5-1 −848 $480.95 $407,846 40,200 D
Open-market sales · 848 sh · avg $480.95 · $407,846
Loading xslF345X05/wk-form4_1740603887.xml…